Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 2
2014 2
2015 1
2016 2
2018 5
2019 5
2020 2
2021 3
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Progress in nanoparticle-based regulation of immune cells.
Fan YN, Zhao G, Zhang Y, Ye QN, Sun YQ, Shen S, Liu Y, Xu CF, Wang J. Fan YN, et al. Among authors: zhao g. Med Rev (2021). 2023 Apr 12;3(2):152-179. doi: 10.1515/mr-2022-0047. eCollection 2023 Apr. Med Rev (2021). 2023. PMID: 37724086 Free PMC article. Review.
Rational designs of in vivo CRISPR-Cas delivery systems.
Xu CF, Chen GJ, Luo YL, Zhang Y, Zhao G, Lu ZD, Czarna A, Gu Z, Wang J. Xu CF, et al. Among authors: zhao g. Adv Drug Deliv Rev. 2021 Jan;168:3-29. doi: 10.1016/j.addr.2019.11.005. Epub 2019 Nov 21. Adv Drug Deliv Rev. 2021. PMID: 31759123 Review.
Multiplexed SERS Barcodes for Anti-Counterfeiting.
Zhou Y, Zhao G, Bian J, Tian X, Cheng X, Wang H, Chen H. Zhou Y, et al. Among authors: zhao g. ACS Appl Mater Interfaces. 2020 Jun 24;12(25):28532-28538. doi: 10.1021/acsami.0c06272. Epub 2020 Jun 15. ACS Appl Mater Interfaces. 2020. PMID: 32483972
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal.
Yu J, Li S, Chen D, Liu D, Guo H, Yang C, Zhang W, Zhang L, Zhao G, Tu X, Peng L, Liu S, Bai X, Song Y, Jiang Z, Zhang R, Tian W. Yu J, et al. Among authors: zhao g. J Hematol Oncol. 2022 Nov 16;15(1):167. doi: 10.1186/s13045-022-01385-2. J Hematol Oncol. 2022. PMID: 36384978 Free PMC article.
IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy.
Li S, Chen D, Guo H, Yang Y, Liu D, Yang C, Bai X, Zhang W, Zhang L, Zhao G, Tu X, Peng L, Liu S, Song Y, Jiang Z, Zhang R, Yu J, Tian W. Li S, et al. Among authors: zhao g. Antib Ther. 2023 Sep 9;6(4):240-252. doi: 10.1093/abt/tbad020. eCollection 2023 Oct. Antib Ther. 2023. PMID: 37846296 Free PMC article.
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A).
Yu J, Li S, Chen D, Liu D, Guo H, Yang C, Zhang W, Zhang L, Zhao G, Tu X, Peng L, Liu S, Bai X, Song Y, Jiang Z, Zhang R, Tian W. Yu J, et al. Among authors: zhao g. Molecules. 2022 Aug 30;27(17):5574. doi: 10.3390/molecules27175574. Molecules. 2022. PMID: 36080360 Free PMC article.
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.
Li S, Chen D, Guo H, Liu D, Yang C, Zhang R, Wang T, Zhang F, Bai X, Yang Y, Sun N, Zhang W, Zhang L, Zhao G, Peng L, Tu X, Tian W. Li S, et al. Among authors: zhao g. Front Oncol. 2023 Oct 2;13:1240061. doi: 10.3389/fonc.2023.1240061. eCollection 2023. Front Oncol. 2023. PMID: 37849799 Free PMC article.
Cinchonidinium chloride monohydrate.
Ni SF, Ma LL, Zhao GF, Sun WJ, Jin ZM. Ni SF, et al. Among authors: zhao gf. Acta Crystallogr Sect E Struct Rep Online. 2007 Dec 6;64(Pt 1):o193. doi: 10.1107/S160053680706343X. Acta Crystallogr Sect E Struct Rep Online. 2007. PMID: 21200758 Free PMC article.
32 results